MedPath

Diphenhydramine HCl

Akron Pharma, Inc.

Approved
Approval ID

3c323dc8-f734-b44c-e063-6394a90a6184

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Aug 12, 2025

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenhydramine HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-3877
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
Diphenhydramine HCl
Product Specifications
Route of AdministrationORAL
Effective DateAugust 12, 2025
FDA Product Classification

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
DIPHENHYDRAMINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: TC2D6JAD40
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 8/12/2025

pdp

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/19/2025

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 1/19/2025

Active ingredient (in each banded capsule)

Diphenhydramine Hydrochloride 25 mg and 50 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 1/19/2025

Purpose

Antihistamine

WARNINGS SECTION

LOINC: 34071-1Updated: 1/19/2025

Warnings

Do not use

  • to make a child sleepy
  • with any other product containing diphenhydramine, even one used on skin

Ask a doctor before use if you have

  • glaucoma
  • difficulty in urination due to enlargement of the prostate gland
  • a breathing problem such as emphysema or chronic bronchitis

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

  • marked drowsiness may occur
  • avoid alcoholic beverages
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • excitability may occur, especially in children
  • be careful when driving a motor vehicle or operating machinery

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/19/2025

Directions

  • take every 4 to 6 hours
  • do not take more than 6 doses in 24 hours

25 mg Dosage:

Age

Dose

adults and children 12 years and over

1 to 2 capsules

children 6 to under 12 years of age

1 capsule

children under 6 years of age

do not use this product in children under 6 years of age

50 mg Dosage:

** Age**

** Dose**

adults and children 12 years and over

1 capsules

children under 12 years of age

ask a doctor, the proper dosage
strength is not available in this
package**

**Do not attempt to break capsules. The proper dosage strength and dosing information for children under 12 years of age is available on the
25 mg. package.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 1/19/2025

Other information

  • store at temperature 15° to 30° C (59° to 86°F)
  • do not use if either capsule band or imprinted safety seal under cap is broken or missing
  • protect from moisture

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 1/19/2025

Inactive ingredients

Colloidal silicon dioxide, Gelatin, Lactose Monohydrate, Magnesium Stearate, Microcrystalline cellulose

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 1/19/2025

Questions or comments?

Call toll-free 1-877-225-6999

Manufactured for:
Akron Pharma, Inc,

373 RT US 46 W, Building E,

Suite 117, Fairfield, NJ 07004

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diphenhydramine HCl - FDA Drug Approval Details